Zusammenfassung
Diabetes mellitus zählt zu den Hauptrisikofaktoren für die Entstehung der koronaren Herzkrankheit, welche bei Diabetikern akzeleriert verläuft und mit einer schlechten Prognose assoziiert ist. Wenngleich bei stabiler koronarer Herzkrankheit durch eine Revaskularisierung mittels Bypass-Operation oder interventionelle Stentimplantation eine schnelle Beschwerdefreiheit erzielt werden kann, so hat dies keinen wesentlichen Einfluss auf die Prognose. Lediglich bei Patienten mit Haupstammstenose oder hochgradiger Stenose des proximalen Ramus interventricularis anterior konnte die Prognose günstig beeinflusst werden. Durch eine multifaktorielle Intervention, die neben Diät, Blutzucker- und Blutdruckeinstellung auch regelmäßiges körperliches Training beinhaltet, kommt es zu einer Verbesserung der modifizierbaren Risikofaktoren und einer Steigerung der beschwerde- und ischämiefreien Belastbarkeit, so dass die multifaktorielle Intervention eine alternative Therapiestrategie darstellt.
Summary
Diabetes mellitus is a major risk factor for coronary artery disease and is associated with accelerated disease progression and adverse prognosis. Although relief of symptoms can quickly be obtained by percutaneous intervention or bypass surgery, it does not change patients’ prognoses, with the exception of stenoses of the left main stem or left anterior descending artery. A multifactorial intervention, which consists of a low-fat diet, glucose and arterial blood pressure control, smoking cessation and regular physical exercise, emerges as an alternative strategy since it leads to improvement of the modifiable risk factors, exercise tolerance and quality of life.
Literatur
1
Abizaid A, Costa M A, Centemero M. et al .
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial.
Circulation.
2001;
104
533-538
2
Aronson D, Rayfield E J, Cheselro J H.
Mechanisms determing course and outcome of diabetic patients who have acute myocardial infarction.
Ann Intern Med.
1997;
126
296-306
3
Batty G D, Shipley M J, Marmot M. et al .
Physical activity and cause-specific mortality in men with Type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study.
Diabet Med.
2002;
19
580-588
4
Collins R, Armitage J, Parish S. et al .
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
Lancet.
2003;
361
2005-2016
5
RITA-2 trial participants .
Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial.
Lancet.
1997;
350
461-468
6
Diegeler A, Thiele H, Falk V. et al .
Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery.
N Engl J Med.
2002;
347
561-566
7
Feener E P, King G L.
Endothelial Dysfunction in Diabetes Mellitus: Role in Cardiovascular Disease.
Heart Fail Monit.
2001;
1
74-82
8
Gaede P, Vedel P, Larsen N. et al .
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
N Engl J Med.
2003;
348
383-393
9
Gohlke H, Kubler W, Mathes P. et al .
Positionspapier zur Primärprevention kardiovaskulärer Erkrankungen: Aktuelle Fassung vom 25.03.2003. Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie, Herz und Kreislauferkrankungen: Bearbeitet im Auftrag des Vorstandes durch die Projektgruppe Prävention.
Z Kardiol.
2003;
92
522-523
10
Goldberg R B, Mellies M J, Sacks F M. et al. The Care Investigators .
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial.
Circulation.
1998;
98
2513-2519
11
Haskell W L, Alderman E L, Fair J M. et al. The Stanford Coronary Risk Intervention Project (SCRIP) .
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease.
Circulation.
1994;
89
975-990
12
Helmrich S P, Ragland D R, Leung R W. et al .
Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.
N Engl J Med.
1991;
325
147-152
13
Hu F B, Manson J E, Stampfer M J. et al .
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
N Engl J Med.
2001;
345
790-797
14
Hu F B, Sigal R J, Rich-Edwards J W. et al .
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study.
JAMA.
1999;
282
1433-1439
15
Hu F B, Stampfer M J, Solomon C. et al .
Physical activity and risk for cardiovascular events in diabetic women.
Ann Intern Med.
2001;
134
96-105
16
Hu F B, Stampfer M J, Haffner S M. et al .
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.
Diabetes Care.
2002;
25
1129-1134
17
Hueb W A, Soares P R, Almeida De Oliveira S. et al .
Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending coronary artery stenosis.
Circulation.
1999;
100
107-113
18
Investigators B.
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI).
Circulation.
1997;
96
1761-1769
19
Jolliffe J A, Rees K, Taylor R S. et al .
Exercise-based rehabilitation for coronary heart disease.
Cochrane Database Syst Rev.
2000;
CD001800
20
Kolenda K D.
Secondary prevention of coronary heart disease. How effective are modern therapy methods?.
Dtsch Med Wochenschr.
2003;
128
1849-1853
21
Laakso M, Lehto S, Penttilä I. et al .
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
Circulation.
1993;
88
1421-1430
22
Lagerqvist B, Husted S, Kontny F. et al .
A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study.
J Am Coll Cardiol.
2002;
40
1902-1914
23
Morice M C, Serruys P W, Sousa J E. et al .
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
N Engl J Med.
2002;
346
1773-1780
24
Moses J W, Leon M B, Pompa J J. et al .
Angiographic and clinical outcomes after a sirolimus-eluting stent compared to a standard stent in patients with complex coronary stenosis.
N Eng J Med.
2003;
in press
25
Niebauer J, Hambrecht R, Velich T. et al .
Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: Role of physical exercise.
Circulation.
1997;
96
2534-2541
26
Niebauer J, Hambrecht R, Velich T. et al .
Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low fat diet and physical exercise program.
Am J Cardiol.
1996;
78
163-167
27
Niebauer J, Cooke J P.
Cardiovascular effects of exercise: role of endothelial shear stress.
J Am Coll Cardiol.
1996;
28
1652-1660
28
Niebauer J, Maxwell A J, Lin P S, Tsao P S, Kosek J, Bernstein D, Cooke J P.
Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training.
Am J Physiol.
1999;
276
H1346-H1354
29
Niebauer J, Maxwell A J, Lin P S. et al .
NOS inhibition accelerates atherogenesis: reversal by exercise.
Am J Physiol Heart Circ Physiol.
2003;
285
H535-H540
30
Niebauer J, Dulak J, Chan J R. et al .
Gene transfer of nitric oxide synthase: effects on endothelial biology.
J Am Coll Cardiol.
1999;
34
1201-1207
31
Ornish D, Scherwitz L W, Billings J H. et al .
Intensive lifestyle changes for reversal of coronary heart disease.
JAMA.
1998;
280
2001-2007
32
Parisi A F, Folland E D, Hartigan P. Veterans Affairs ACME Investigators .
A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease.
N Engl J Med.
1992;
326
10-16
33
Peschel T, Beitz F, Tarnok A. et al .
Diabetes mellitus type 2 is associated with upregulation of atherogenic surface markers: Normalization through exercise training (abstr).
Circulation.
2002;
106
712
34
Pyorala K, Pedersen T R, Kjekshus J. et al .
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
Diabetes Care.
1997;
20
614-620
35
Schachinger V, Britten M B, Zeiher A M.
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.
Circulation.
2000;
101
1899-1906
36
Schuler G, Hambrecht R, Schlierf G. et al .
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Circulation.
1992;
86
1-11
37
Schuler G, Hambrecht R, Schlierf G. et al .
Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet.
J Am Coll Cardiol.
1992;
19
34-42
38
Sculpher M, Smith D, Clayton T. et al .
Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial.
Eur Heart J.
2002;
23
1291-1300
39
Sobel B E, Frye R, Detre K M.
Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Circulation.
2003;
107
636-642
40
Stamler J, Vaccaro O, Neaton J D. et al .
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.
Diabetes Care.
1993;
16
434-444
41
Syvänna M, Taskinen M R.
Lipids and lipoproteins as coronary risk factor in non-insulin-dependent diabetes mellitus.
Lancet.
1997;
350
20-23
42
Tanasescu M, Leitzmann M F, Rimm E B, Hu F B.
Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
Circulation.
2003;
107
2435-2439
43
UK Prospective Diabetes Study Group .
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.
BMJ.
1998;
317
703-713
44
Tuomilehto J, Lindstrom J, Eriksson J G. et al .
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
N Engl J Med.
2001;
344
1343-1350
45
Turner R, Cull C, Holman R.
United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomised, controlled trial on the effect of improved metabolic control on complications in NIDDM.
Ann Intern Med.
1996;
124
136-145
46
Turner R C, Millns H, Neil H A. et al .
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23).
BMJ.
1998;
316
823-828
47
Webster M WI, Scott R S.
What cardiologists need to know about diabetes.
Lancet.
1997;
350
23-28
48
Wei M, Gibbons L W, Mitchell T L. et al .
The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men.
Ann Intern Med.
1999;
130
89-96
49
Wei M, Gibbons L W, Kampert J B. et al .
Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes.
Ann Intern Med.
2000;
132
605-611
Priv.-Doz. Dr. Dr. Josef Niebauer
Herzzentrum der Universität Leipzig
Strümpellstraße 39
04289 Leipzig
Telefon: +49/341/8650
Fax: +49/341/8651461
eMail: j.niebauer@medizin.uni-leipzig.de